New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options

Franco Naccarella; Chen Liying; Gerald Naccarelli; Stefano Sdringola Maranga; Giovannina Lepera; Mauro Gatti; Stefano Pazzaglia; Giovanna Spinelli; Barbara Bresciani; Ettore Ambrosioni; Claudio Borghi; Giorgio Arpesella

New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options

Franco Naccarella, Chen Liying, Gerald Naccarelli, Stefano Sdringola Maranga, Giovannina Lepera, Mauro Gatti, Stefano Pazzaglia, Giovanna Spinelli, Barbara Bresciani, Ettore Ambrosioni, Claudio Borghi, Giorgio Arpesella

Research output: Contribution to journal › Review article › peer-review

Abstract

Acutely decompensated heart failure (ADHF) represents the leading reason for hospital admissions in patients over 65 years of age. Aim of this paper is to analyze new approaches for acute heart failure treatment. Effective new treatments should be found to reduce the length of hospital stay and its correlate costs in CHF symptomatic and asymptomatic patients. According to the Authors' personal experience and new clinical data from controlled clinical trials, it is mandatory to substitute traditional inotropes, in acutely decompensated heart failure, as first option, with the advice to use alternative drugs, at least in patients with the cardio renal syndrome. The Author consider the possibility of treatment of ADHF trying toblock mainly compensatory systems and neurohermons.

Original language	English (US)
Pages (from-to)	7-24
Number of pages	18
Journal	Mediterranean Journal of Pacing and Electrophysiology
Volume	6
Issue number	1
State	Published - Jan 2004

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Physiology (medical)

Cite this

@article{b3510366d8574f1794416e5b632ad8d2,

title = "New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options",

abstract = "Acutely decompensated heart failure (ADHF) represents the leading reason for hospital admissions in patients over 65 years of age. Aim of this paper is to analyze new approaches for acute heart failure treatment. Effective new treatments should be found to reduce the length of hospital stay and its correlate costs in CHF symptomatic and asymptomatic patients. According to the Authors' personal experience and new clinical data from controlled clinical trials, it is mandatory to substitute traditional inotropes, in acutely decompensated heart failure, as first option, with the advice to use alternative drugs, at least in patients with the cardio renal syndrome. The Author consider the possibility of treatment of ADHF trying toblock mainly compensatory systems and neurohermons.",

author = "Franco Naccarella and Chen Liying and Gerald Naccarelli and Maranga, {Stefano Sdringola} and Giovannina Lepera and Mauro Gatti and Stefano Pazzaglia and Giovanna Spinelli and Barbara Bresciani and Ettore Ambrosioni and Claudio Borghi and Giorgio Arpesella",

year = "2004",

month = jan,

language = "English (US)",

volume = "6",

pages = "7--24",

journal = "Mediterranean Journal of Pacing and Electrophysiology",

issn = "1128-4293",

publisher = "Edizioni Luigi Pozzi S.r.l.",

number = "1",

}

TY - JOUR

T1 - New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options

AU - Naccarella, Franco

AU - Liying, Chen

AU - Naccarelli, Gerald

AU - Maranga, Stefano Sdringola

AU - Lepera, Giovannina

AU - Gatti, Mauro

AU - Pazzaglia, Stefano

AU - Spinelli, Giovanna

AU - Bresciani, Barbara

AU - Ambrosioni, Ettore

AU - Borghi, Claudio

AU - Arpesella, Giorgio

PY - 2004/1

Y1 - 2004/1

N2 - Acutely decompensated heart failure (ADHF) represents the leading reason for hospital admissions in patients over 65 years of age. Aim of this paper is to analyze new approaches for acute heart failure treatment. Effective new treatments should be found to reduce the length of hospital stay and its correlate costs in CHF symptomatic and asymptomatic patients. According to the Authors' personal experience and new clinical data from controlled clinical trials, it is mandatory to substitute traditional inotropes, in acutely decompensated heart failure, as first option, with the advice to use alternative drugs, at least in patients with the cardio renal syndrome. The Author consider the possibility of treatment of ADHF trying toblock mainly compensatory systems and neurohermons.

AB - Acutely decompensated heart failure (ADHF) represents the leading reason for hospital admissions in patients over 65 years of age. Aim of this paper is to analyze new approaches for acute heart failure treatment. Effective new treatments should be found to reduce the length of hospital stay and its correlate costs in CHF symptomatic and asymptomatic patients. According to the Authors' personal experience and new clinical data from controlled clinical trials, it is mandatory to substitute traditional inotropes, in acutely decompensated heart failure, as first option, with the advice to use alternative drugs, at least in patients with the cardio renal syndrome. The Author consider the possibility of treatment of ADHF trying toblock mainly compensatory systems and neurohermons.

UR - http://www.scopus.com/inward/record.url?scp=4444366255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444366255&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:4444366255

SN - 1128-4293

VL - 6

SP - 7

EP - 24

JO - Mediterranean Journal of Pacing and Electrophysiology

JF - Mediterranean Journal of Pacing and Electrophysiology

IS - 1

ER -

New pharmacological treatments of acutely decompensated heart failure. Critical review of new drug options

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this